Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07083765

Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)

A Prospective Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation Using the Dehydrated Alcohol Injection, USP Administered With the Peregrine System™ Infusion Catheter in Subjects With Hypertension, in the Absence of Antihypertensive Medications

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
142 (estimated)
Sponsor
Ablative Solutions, Inc. · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To obtain an assessment of the efficacy and safety of renal denervation by dehydrated alcohol injection, USP administered via the Peregrine System™ Infusion Catheter in hypertensive subjects in the absence of antihypertensive medications.

Detailed description

This Phase 3, prospective, randomized, blinded, sham procedure-controlled, multicenter study will assess the efficacy and safety of renal denervation by alcohol-mediated neurolysis using the Peregrine Catheter in hypertensive subjects in the absence of antihypertensive medications. Subjects with a documented history of uncontrolled hypertension who are taking 0, 1, or 2 antihypertensive medications at enrollment will be recruited. After providing written informed consent, subjects will undergo screening assessments to assess eligibility for the study. Eligible subjects will then enter a run in period during which they will take no antihypertensive medications. Subjects who continue to be eligible at the end of the run-in period will complete the study Baseline visit and remain without taking antihypertensive medications. Subjects who continue to be eligible after the completion of the Baseline visit will attend the study site and will be randomized to either the Treatment Arm (renal denervation using the Peregrine Catheter) or the Sham Control Arm (renal angiography only). After study unblinding, crossover from the Sham Control Arm to the Treatment Arm may be allowed, at the discretion of the treating investigator.

Conditions

Interventions

TypeNameDescription
DRUGDehydrated Alcohol Injection, USPAlcohol is directly infused/delivered to the adventitial and periadventitial space of the renal arteries
PROCEDURESham procedureEndovascular, renal angiography

Timeline

Start date
2025-09-01
Primary completion
2027-06-01
Completion
2027-10-31
First posted
2025-07-24
Last updated
2025-09-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07083765. Inclusion in this directory is not an endorsement.